nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—ovarian cancer	0.38	0.563	CbGbCtD
L-Carnitine—MPO—Carboplatin—ovarian cancer	0.114	0.17	CbGbCtD
L-Carnitine—XDH—Carboplatin—ovarian cancer	0.114	0.17	CbGbCtD
L-Carnitine—XDH—Doxorubicin—ovarian cancer	0.0655	0.0971	CbGbCtD
L-Carnitine—SLC22A16—gonad—ovarian cancer	0.00367	0.0253	CbGeAlD
L-Carnitine—SLC25A20—myometrium—ovarian cancer	0.00353	0.0244	CbGeAlD
L-Carnitine—CRAT—myometrium—ovarian cancer	0.00343	0.0236	CbGeAlD
L-Carnitine—SLC22A16—female reproductive system—ovarian cancer	0.00327	0.0226	CbGeAlD
L-Carnitine—CROT—uterine cervix—ovarian cancer	0.00316	0.0218	CbGeAlD
L-Carnitine—SLC25A29—endometrium—ovarian cancer	0.00312	0.0215	CbGeAlD
L-Carnitine—SLC22A16—bone marrow—ovarian cancer	0.00309	0.0213	CbGeAlD
L-Carnitine—CROT—decidua—ovarian cancer	0.00301	0.0208	CbGeAlD
L-Carnitine—SLC25A20—uterine cervix—ovarian cancer	0.00275	0.019	CbGeAlD
L-Carnitine—CRAT—uterine cervix—ovarian cancer	0.00267	0.0184	CbGeAlD
L-Carnitine—SLC22A16—testis—ovarian cancer	0.00264	0.0182	CbGeAlD
L-Carnitine—CPT2—myometrium—ovarian cancer	0.00264	0.0182	CbGeAlD
L-Carnitine—CROT—uterus—ovarian cancer	0.00263	0.0182	CbGeAlD
L-Carnitine—SLC25A20—decidua—ovarian cancer	0.00262	0.0181	CbGeAlD
L-Carnitine—SLC25A29—female reproductive system—ovarian cancer	0.00258	0.0178	CbGeAlD
L-Carnitine—CRAT—decidua—ovarian cancer	0.00254	0.0175	CbGeAlD
L-Carnitine—SLC25A20—endometrium—ovarian cancer	0.00249	0.0172	CbGeAlD
L-Carnitine—CRAT—endometrium—ovarian cancer	0.00241	0.0166	CbGeAlD
L-Carnitine—CROT—female reproductive system—ovarian cancer	0.00237	0.0163	CbGeAlD
L-Carnitine—SLC25A29—female gonad—ovarian cancer	0.00235	0.0162	CbGeAlD
L-Carnitine—SLC25A20—uterus—ovarian cancer	0.00229	0.0158	CbGeAlD
L-Carnitine—CRAT—gonad—ovarian cancer	0.00224	0.0154	CbGeAlD
L-Carnitine—CROT—bone marrow—ovarian cancer	0.00223	0.0154	CbGeAlD
L-Carnitine—CRAT—uterus—ovarian cancer	0.00222	0.0153	CbGeAlD
L-Carnitine—CROT—female gonad—ovarian cancer	0.00215	0.0149	CbGeAlD
L-Carnitine—CROT—vagina—ovarian cancer	0.00214	0.0148	CbGeAlD
L-Carnitine—SLC25A29—testis—ovarian cancer	0.00208	0.0144	CbGeAlD
L-Carnitine—SLC25A20—female reproductive system—ovarian cancer	0.00206	0.0142	CbGeAlD
L-Carnitine—CPT2—uterine cervix—ovarian cancer	0.00205	0.0142	CbGeAlD
L-Carnitine—CRAT—female reproductive system—ovarian cancer	0.002	0.0138	CbGeAlD
L-Carnitine—CPT2—decidua—ovarian cancer	0.00195	0.0135	CbGeAlD
L-Carnitine—SLC25A20—bone marrow—ovarian cancer	0.00194	0.0134	CbGeAlD
L-Carnitine—CROT—testis—ovarian cancer	0.00191	0.0132	CbGeAlD
L-Carnitine—CRAT—bone marrow—ovarian cancer	0.00189	0.013	CbGeAlD
L-Carnitine—SLC25A20—female gonad—ovarian cancer	0.00187	0.0129	CbGeAlD
L-Carnitine—SLC25A20—vagina—ovarian cancer	0.00186	0.0128	CbGeAlD
L-Carnitine—CPT2—endometrium—ovarian cancer	0.00185	0.0128	CbGeAlD
L-Carnitine—CRAT—female gonad—ovarian cancer	0.00182	0.0125	CbGeAlD
L-Carnitine—CPT1A—gonad—ovarian cancer	0.00181	0.0125	CbGeAlD
L-Carnitine—CRAT—vagina—ovarian cancer	0.00181	0.0125	CbGeAlD
L-Carnitine—CPT2—gonad—ovarian cancer	0.00172	0.0119	CbGeAlD
L-Carnitine—CPT2—uterus—ovarian cancer	0.00171	0.0118	CbGeAlD
L-Carnitine—SLC25A20—testis—ovarian cancer	0.00166	0.0115	CbGeAlD
L-Carnitine—CPT1A—female reproductive system—ovarian cancer	0.00162	0.0112	CbGeAlD
L-Carnitine—CRAT—testis—ovarian cancer	0.00161	0.0111	CbGeAlD
L-Carnitine—XDH—uterine cervix—ovarian cancer	0.0016	0.011	CbGeAlD
L-Carnitine—CPT2—female reproductive system—ovarian cancer	0.00154	0.0106	CbGeAlD
L-Carnitine—SLC25A29—lymph node—ovarian cancer	0.00151	0.0104	CbGeAlD
L-Carnitine—CPT1A—female gonad—ovarian cancer	0.00147	0.0102	CbGeAlD
L-Carnitine—CPT1A—vagina—ovarian cancer	0.00146	0.0101	CbGeAlD
L-Carnitine—CPT2—bone marrow—ovarian cancer	0.00145	0.01	CbGeAlD
L-Carnitine—XDH—endometrium—ovarian cancer	0.00144	0.00997	CbGeAlD
L-Carnitine—CPT2—female gonad—ovarian cancer	0.0014	0.00965	CbGeAlD
L-Carnitine—CPT2—vagina—ovarian cancer	0.00139	0.00959	CbGeAlD
L-Carnitine—CROT—lymph node—ovarian cancer	0.00138	0.00955	CbGeAlD
L-Carnitine—CPT1A—testis—ovarian cancer	0.00131	0.00902	CbGeAlD
L-Carnitine—CPT2—testis—ovarian cancer	0.00124	0.00856	CbGeAlD
L-Carnitine—SLC25A20—lymph node—ovarian cancer	0.0012	0.00831	CbGeAlD
L-Carnitine—XDH—female reproductive system—ovarian cancer	0.0012	0.00826	CbGeAlD
L-Carnitine—SLC22A4—myometrium—ovarian cancer	0.00119	0.00824	CbGeAlD
L-Carnitine—CRAT—lymph node—ovarian cancer	0.00117	0.00806	CbGeAlD
L-Carnitine—XDH—vagina—ovarian cancer	0.00108	0.00747	CbGeAlD
L-Carnitine—MPO—epithelium—ovarian cancer	0.00103	0.00708	CbGeAlD
L-Carnitine—CPT1A—lymph node—ovarian cancer	0.000947	0.00654	CbGeAlD
L-Carnitine—CES1—female reproductive system—ovarian cancer	0.000913	0.0063	CbGeAlD
L-Carnitine—CPT2—lymph node—ovarian cancer	0.000899	0.0062	CbGeAlD
L-Carnitine—SLC22A4—decidua—ovarian cancer	0.000885	0.00611	CbGeAlD
L-Carnitine—SLC22A4—endometrium—ovarian cancer	0.00084	0.0058	CbGeAlD
L-Carnitine—CES1—female gonad—ovarian cancer	0.00083	0.00573	CbGeAlD
L-Carnitine—SLC22A5—myometrium—ovarian cancer	0.00079	0.00545	CbGeAlD
L-Carnitine—SLCO1B1—female reproductive system—ovarian cancer	0.000784	0.00541	CbGeAlD
L-Carnitine—CES1—testis—ovarian cancer	0.000736	0.00508	CbGeAlD
L-Carnitine—MPO—bone marrow—ovarian cancer	0.000719	0.00496	CbGeAlD
L-Carnitine—SLC22A4—female reproductive system—ovarian cancer	0.000696	0.0048	CbGeAlD
L-Carnitine—SLC22A4—bone marrow—ovarian cancer	0.000657	0.00453	CbGeAlD
L-Carnitine—SLC22A4—vagina—ovarian cancer	0.000629	0.00434	CbGeAlD
L-Carnitine—MPO—testis—ovarian cancer	0.000615	0.00424	CbGeAlD
L-Carnitine—SLC22A5—uterine cervix—ovarian cancer	0.000615	0.00424	CbGeAlD
L-Carnitine—SLC22A5—endometrium—ovarian cancer	0.000556	0.00384	CbGeAlD
L-Carnitine—CES1—lymph node—ovarian cancer	0.000534	0.00368	CbGeAlD
L-Carnitine—SLC22A5—female reproductive system—ovarian cancer	0.00046	0.00318	CbGeAlD
L-Carnitine—MPO—lymph node—ovarian cancer	0.000446	0.00308	CbGeAlD
L-Carnitine—SLC22A5—female gonad—ovarian cancer	0.000419	0.00289	CbGeAlD
L-Carnitine—SLC22A5—vagina—ovarian cancer	0.000416	0.00287	CbGeAlD
L-Carnitine—SLC22A4—lymph node—ovarian cancer	0.000407	0.00281	CbGeAlD
L-Carnitine—SLC22A5—testis—ovarian cancer	0.000372	0.00256	CbGeAlD
L-Carnitine—Haemorrhage—Paclitaxel—ovarian cancer	0.000359	0.00283	CcSEcCtD
L-Carnitine—Hypertonia—Epirubicin—ovarian cancer	0.000359	0.00282	CcSEcCtD
L-Carnitine—Asthenia—Chlorambucil—ovarian cancer	0.000358	0.00282	CcSEcCtD
L-Carnitine—Pharyngitis—Paclitaxel—ovarian cancer	0.000357	0.00281	CcSEcCtD
L-Carnitine—Hypotension—Vinorelbine—ovarian cancer	0.000355	0.00279	CcSEcCtD
L-Carnitine—Oedema peripheral—Paclitaxel—ovarian cancer	0.000354	0.00279	CcSEcCtD
L-Carnitine—Pruritus—Chlorambucil—ovarian cancer	0.000353	0.00278	CcSEcCtD
L-Carnitine—Abdominal pain—Topotecan—ovarian cancer	0.000351	0.00276	CcSEcCtD
L-Carnitine—Body temperature increased—Topotecan—ovarian cancer	0.000351	0.00276	CcSEcCtD
L-Carnitine—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.000348	0.00274	CcSEcCtD
L-Carnitine—Weight increased—Docetaxel—ovarian cancer	0.000346	0.00273	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000346	0.00272	CcSEcCtD
L-Carnitine—Weight decreased—Docetaxel—ovarian cancer	0.000344	0.00271	CcSEcCtD
L-Carnitine—Diarrhoea—Chlorambucil—ovarian cancer	0.000341	0.00268	CcSEcCtD
L-Carnitine—Paraesthesia—Vinorelbine—ovarian cancer	0.000341	0.00268	CcSEcCtD
L-Carnitine—Dyspnoea—Vinorelbine—ovarian cancer	0.000338	0.00266	CcSEcCtD
L-Carnitine—Eye disorder—Paclitaxel—ovarian cancer	0.000336	0.00264	CcSEcCtD
L-Carnitine—Renal failure—Docetaxel—ovarian cancer	0.000333	0.00263	CcSEcCtD
L-Carnitine—Hypertonia—Doxorubicin—ovarian cancer	0.000332	0.00261	CcSEcCtD
L-Carnitine—Decreased appetite—Vinorelbine—ovarian cancer	0.00033	0.0026	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000328	0.00258	CcSEcCtD
L-Carnitine—Hypersensitivity—Topotecan—ovarian cancer	0.000327	0.00257	CcSEcCtD
L-Carnitine—Angiopathy—Paclitaxel—ovarian cancer	0.000326	0.00257	CcSEcCtD
L-Carnitine—Constipation—Vinorelbine—ovarian cancer	0.000325	0.00256	CcSEcCtD
L-Carnitine—Pain—Vinorelbine—ovarian cancer	0.000325	0.00256	CcSEcCtD
L-Carnitine—Arrhythmia—Paclitaxel—ovarian cancer	0.000321	0.00253	CcSEcCtD
L-Carnitine—Hypersensitivity—Melphalan—ovarian cancer	0.00032	0.00252	CcSEcCtD
L-Carnitine—Asthenia—Topotecan—ovarian cancer	0.000318	0.00251	CcSEcCtD
L-Carnitine—Vomiting—Chlorambucil—ovarian cancer	0.000317	0.00249	CcSEcCtD
L-Carnitine—Pruritus—Topotecan—ovarian cancer	0.000314	0.00247	CcSEcCtD
L-Carnitine—Asthenia—Melphalan—ovarian cancer	0.000312	0.00245	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00031	0.00244	CcSEcCtD
L-Carnitine—Pruritus—Melphalan—ovarian cancer	0.000307	0.00242	CcSEcCtD
L-Carnitine—Dysgeusia—Paclitaxel—ovarian cancer	0.000306	0.00241	CcSEcCtD
L-Carnitine—Haemoglobin—Docetaxel—ovarian cancer	0.000306	0.00241	CcSEcCtD
L-Carnitine—Rhinitis—Docetaxel—ovarian cancer	0.000305	0.0024	CcSEcCtD
L-Carnitine—Haemorrhage—Docetaxel—ovarian cancer	0.000305	0.0024	CcSEcCtD
L-Carnitine—Diarrhoea—Topotecan—ovarian cancer	0.000304	0.00239	CcSEcCtD
L-Carnitine—Back pain—Paclitaxel—ovarian cancer	0.000303	0.00238	CcSEcCtD
L-Carnitine—Pharyngitis—Docetaxel—ovarian cancer	0.000302	0.00238	CcSEcCtD
L-Carnitine—Muscle spasms—Paclitaxel—ovarian cancer	0.000301	0.00237	CcSEcCtD
L-Carnitine—Abdominal pain—Vinorelbine—ovarian cancer	0.0003	0.00236	CcSEcCtD
L-Carnitine—Body temperature increased—Vinorelbine—ovarian cancer	0.0003	0.00236	CcSEcCtD
L-Carnitine—Oedema peripheral—Docetaxel—ovarian cancer	0.0003	0.00236	CcSEcCtD
L-Carnitine—Diarrhoea—Melphalan—ovarian cancer	0.000297	0.00234	CcSEcCtD
L-Carnitine—Nausea—Chlorambucil—ovarian cancer	0.000296	0.00233	CcSEcCtD
L-Carnitine—Dizziness—Topotecan—ovarian cancer	0.000293	0.00231	CcSEcCtD
L-Carnitine—Anaemia—Paclitaxel—ovarian cancer	0.000289	0.00228	CcSEcCtD
L-Carnitine—Eye disorder—Docetaxel—ovarian cancer	0.000285	0.00224	CcSEcCtD
L-Carnitine—Vomiting—Topotecan—ovarian cancer	0.000282	0.00222	CcSEcCtD
L-Carnitine—Vertigo—Paclitaxel—ovarian cancer	0.000281	0.00221	CcSEcCtD
L-Carnitine—Rash—Topotecan—ovarian cancer	0.00028	0.0022	CcSEcCtD
L-Carnitine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00028	0.0022	CcSEcCtD
L-Carnitine—Dermatitis—Topotecan—ovarian cancer	0.000279	0.0022	CcSEcCtD
L-Carnitine—Headache—Topotecan—ovarian cancer	0.000278	0.00219	CcSEcCtD
L-Carnitine—Palpitations—Paclitaxel—ovarian cancer	0.000276	0.00218	CcSEcCtD
L-Carnitine—Angiopathy—Docetaxel—ovarian cancer	0.000276	0.00218	CcSEcCtD
L-Carnitine—Vomiting—Melphalan—ovarian cancer	0.000276	0.00217	CcSEcCtD
L-Carnitine—Rash—Melphalan—ovarian cancer	0.000274	0.00216	CcSEcCtD
L-Carnitine—Dermatitis—Melphalan—ovarian cancer	0.000274	0.00215	CcSEcCtD
L-Carnitine—Cough—Paclitaxel—ovarian cancer	0.000273	0.00215	CcSEcCtD
L-Carnitine—Asthenia—Vinorelbine—ovarian cancer	0.000272	0.00214	CcSEcCtD
L-Carnitine—Arrhythmia—Docetaxel—ovarian cancer	0.000272	0.00214	CcSEcCtD
L-Carnitine—Convulsion—Paclitaxel—ovarian cancer	0.000271	0.00213	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—SLC2A1—ovarian cancer	0.000271	0.005	CbGpPWpGaD
L-Carnitine—Hypertension—Paclitaxel—ovarian cancer	0.00027	0.00213	CcSEcCtD
L-Carnitine—SLC22A5—lymph node—ovarian cancer	0.000269	0.00186	CbGeAlD
L-Carnitine—Pruritus—Vinorelbine—ovarian cancer	0.000268	0.00211	CcSEcCtD
L-Carnitine—Chest pain—Paclitaxel—ovarian cancer	0.000266	0.0021	CcSEcCtD
L-Carnitine—Myalgia—Paclitaxel—ovarian cancer	0.000266	0.0021	CcSEcCtD
L-Carnitine—Anxiety—Paclitaxel—ovarian cancer	0.000265	0.00209	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—PIK3CB—ovarian cancer	0.000264	0.00487	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—MTOR—ovarian cancer	0.000264	0.00487	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000264	0.00487	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000264	0.00487	CbGpPWpGaD
L-Carnitine—Nausea—Topotecan—ovarian cancer	0.000263	0.00207	CcSEcCtD
L-Carnitine—Gastritis—Epirubicin—ovarian cancer	0.000263	0.00207	CcSEcCtD
L-Carnitine—Muscular weakness—Epirubicin—ovarian cancer	0.000262	0.00206	CcSEcCtD
L-Carnitine—Diarrhoea—Vinorelbine—ovarian cancer	0.00026	0.00204	CcSEcCtD
L-Carnitine—Dysgeusia—Docetaxel—ovarian cancer	0.00026	0.00204	CcSEcCtD
L-Carnitine—Nausea—Melphalan—ovarian cancer	0.000258	0.00203	CcSEcCtD
L-Carnitine—Influenza—Epirubicin—ovarian cancer	0.000257	0.00202	CcSEcCtD
L-Carnitine—Back pain—Docetaxel—ovarian cancer	0.000256	0.00202	CcSEcCtD
L-Carnitine—Muscle spasms—Docetaxel—ovarian cancer	0.000255	0.00201	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—STAT3—ovarian cancer	0.000254	0.00469	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD2—ovarian cancer	0.000254	0.00468	CbGpPWpGaD
L-Carnitine—Infection—Paclitaxel—ovarian cancer	0.000254	0.002	CcSEcCtD
L-Carnitine—CROT—Metabolism—PPP1CC—ovarian cancer	0.000253	0.00466	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—BRIP1—ovarian cancer	0.000253	0.00466	CbGpPWpGaD
L-Carnitine—Dizziness—Vinorelbine—ovarian cancer	0.000251	0.00198	CcSEcCtD
L-Carnitine—Tachycardia—Paclitaxel—ovarian cancer	0.000249	0.00196	CcSEcCtD
L-Carnitine—Bronchitis—Epirubicin—ovarian cancer	0.000247	0.00194	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CYTB—ovarian cancer	0.000246	0.00453	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYTB—ovarian cancer	0.000246	0.00453	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—NME2—ovarian cancer	0.000246	0.00453	CbGpPWpGaD
L-Carnitine—Anaemia—Docetaxel—ovarian cancer	0.000245	0.00193	CcSEcCtD
L-Carnitine—Anorexia—Paclitaxel—ovarian cancer	0.000243	0.00192	CcSEcCtD
L-Carnitine—Gastritis—Doxorubicin—ovarian cancer	0.000243	0.00191	CcSEcCtD
L-Carnitine—Muscular weakness—Doxorubicin—ovarian cancer	0.000242	0.00191	CcSEcCtD
L-Carnitine—Vomiting—Vinorelbine—ovarian cancer	0.000241	0.0019	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00024	0.00443	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00024	0.00443	CbGpPWpGaD
L-Carnitine—Rash—Vinorelbine—ovarian cancer	0.000239	0.00188	CcSEcCtD
L-Carnitine—Dermatitis—Vinorelbine—ovarian cancer	0.000239	0.00188	CcSEcCtD
L-Carnitine—Hypotension—Paclitaxel—ovarian cancer	0.000239	0.00188	CcSEcCtD
L-Carnitine—Headache—Vinorelbine—ovarian cancer	0.000238	0.00187	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—ovarian cancer	0.000237	0.00187	CcSEcCtD
L-Carnitine—Palpitations—Docetaxel—ovarian cancer	0.000234	0.00184	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—ovarian cancer	0.000234	0.00184	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000233	0.00183	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—ovarian cancer	0.000232	0.00183	CcSEcCtD
L-Carnitine—Cough—Docetaxel—ovarian cancer	0.000231	0.00182	CcSEcCtD
L-Carnitine—Insomnia—Paclitaxel—ovarian cancer	0.000231	0.00182	CcSEcCtD
L-Carnitine—Convulsion—Docetaxel—ovarian cancer	0.00023	0.00181	CcSEcCtD
L-Carnitine—Paraesthesia—Paclitaxel—ovarian cancer	0.000229	0.0018	CcSEcCtD
L-Carnitine—Hypertension—Docetaxel—ovarian cancer	0.000229	0.0018	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000229	0.00422	CbGpPWpGaD
L-Carnitine—Bronchitis—Doxorubicin—ovarian cancer	0.000228	0.0018	CcSEcCtD
L-Carnitine—Dyspnoea—Paclitaxel—ovarian cancer	0.000228	0.00179	CcSEcCtD
L-Carnitine—Myalgia—Docetaxel—ovarian cancer	0.000226	0.00178	CcSEcCtD
L-Carnitine—Chest pain—Docetaxel—ovarian cancer	0.000226	0.00178	CcSEcCtD
L-Carnitine—Nausea—Vinorelbine—ovarian cancer	0.000225	0.00178	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—ovarian cancer	0.000225	0.00177	CcSEcCtD
L-Carnitine—Dyspepsia—Paclitaxel—ovarian cancer	0.000225	0.00177	CcSEcCtD
L-Carnitine—Urinary tract infection—Epirubicin—ovarian cancer	0.000222	0.00175	CcSEcCtD
L-Carnitine—Decreased appetite—Paclitaxel—ovarian cancer	0.000222	0.00175	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00022	0.00174	CcSEcCtD
L-Carnitine—Constipation—Paclitaxel—ovarian cancer	0.000218	0.00172	CcSEcCtD
L-Carnitine—Pain—Paclitaxel—ovarian cancer	0.000218	0.00172	CcSEcCtD
L-Carnitine—Weight increased—Doxorubicin—ovarian cancer	0.000216	0.0017	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000215	0.00397	CbGpPWpGaD
L-Carnitine—Infection—Docetaxel—ovarian cancer	0.000215	0.00169	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—ovarian cancer	0.000215	0.00169	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—PPP1CC—ovarian cancer	0.000215	0.00396	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPP1CC—ovarian cancer	0.000215	0.00396	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—BRIP1—ovarian cancer	0.000215	0.00396	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—BRIP1—ovarian cancer	0.000215	0.00396	CbGpPWpGaD
L-Carnitine—Sinusitis—Epirubicin—ovarian cancer	0.000215	0.00169	CcSEcCtD
L-Carnitine—Tachycardia—Docetaxel—ovarian cancer	0.000211	0.00166	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000209	0.00164	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000208	0.00385	CbGpPWpGaD
L-Carnitine—Renal failure—Doxorubicin—ovarian cancer	0.000208	0.00164	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—ovarian cancer	0.000206	0.00163	CcSEcCtD
L-Carnitine—Anorexia—Docetaxel—ovarian cancer	0.000206	0.00162	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—ovarian cancer	0.000206	0.00162	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000206	0.00162	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—ovarian cancer	0.000205	0.00162	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—ovarian cancer	0.000204	0.00161	CcSEcCtD
L-Carnitine—Oedema peripheral—Epirubicin—ovarian cancer	0.000202	0.00159	CcSEcCtD
L-Carnitine—Hypotension—Docetaxel—ovarian cancer	0.000202	0.00159	CcSEcCtD
L-Carnitine—Body temperature increased—Paclitaxel—ovarian cancer	0.000202	0.00159	CcSEcCtD
L-Carnitine—Abdominal pain—Paclitaxel—ovarian cancer	0.000202	0.00159	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000201	0.00371	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—PIK3CA—ovarian cancer	0.000201	0.0037	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TYMS—ovarian cancer	0.000199	0.00368	CbGpPWpGaD
L-Carnitine—Sinusitis—Doxorubicin—ovarian cancer	0.000199	0.00156	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000197	0.00155	CcSEcCtD
L-Carnitine—Insomnia—Docetaxel—ovarian cancer	0.000196	0.00154	CcSEcCtD
L-Carnitine—Paraesthesia—Docetaxel—ovarian cancer	0.000194	0.00153	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000194	0.00358	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CDKN1B—ovarian cancer	0.000193	0.00356	CbGpPWpGaD
L-Carnitine—Dyspnoea—Docetaxel—ovarian cancer	0.000193	0.00152	CcSEcCtD
L-Carnitine—Eye disorder—Epirubicin—ovarian cancer	0.000192	0.00151	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—ovarian cancer	0.000191	0.0015	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—ovarian cancer	0.000191	0.0015	CcSEcCtD
L-Carnitine—Dyspepsia—Docetaxel—ovarian cancer	0.00019	0.0015	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL2—ovarian cancer	0.00019	0.00351	CbGpPWpGaD
L-Carnitine—Haemorrhage—Doxorubicin—ovarian cancer	0.00019	0.0015	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—ovarian cancer	0.000189	0.00149	CcSEcCtD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000188	0.00347	CbGpPWpGaD
L-Carnitine—Decreased appetite—Docetaxel—ovarian cancer	0.000188	0.00148	CcSEcCtD
L-Carnitine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000188	0.00148	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000187	0.00147	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000187	0.00147	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—ovarian cancer	0.000186	0.00147	CcSEcCtD
L-Carnitine—Pain—Docetaxel—ovarian cancer	0.000185	0.00146	CcSEcCtD
L-Carnitine—Constipation—Docetaxel—ovarian cancer	0.000185	0.00146	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000184	0.0034	CbGpPWpGaD
L-Carnitine—Arrhythmia—Epirubicin—ovarian cancer	0.000183	0.00144	CcSEcCtD
L-Carnitine—Asthenia—Paclitaxel—ovarian cancer	0.000183	0.00144	CcSEcCtD
L-Carnitine—Pruritus—Paclitaxel—ovarian cancer	0.000181	0.00142	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL6—ovarian cancer	0.000178	0.00328	CbGpPWpGaD
L-Carnitine—Eye disorder—Doxorubicin—ovarian cancer	0.000178	0.0014	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000177	0.00139	CcSEcCtD
L-Carnitine—Dysgeusia—Epirubicin—ovarian cancer	0.000175	0.00138	CcSEcCtD
L-Carnitine—Diarrhoea—Paclitaxel—ovarian cancer	0.000175	0.00138	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—ovarian cancer	0.000173	0.00136	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—ovarian cancer	0.000172	0.00136	CcSEcCtD
L-Carnitine—Muscle spasms—Epirubicin—ovarian cancer	0.000172	0.00135	CcSEcCtD
L-Carnitine—Body temperature increased—Docetaxel—ovarian cancer	0.000171	0.00135	CcSEcCtD
L-Carnitine—Abdominal pain—Docetaxel—ovarian cancer	0.000171	0.00135	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—NME2—ovarian cancer	0.00017	0.00314	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00017	0.00314	CbGpPWpGaD
L-Carnitine—Arrhythmia—Doxorubicin—ovarian cancer	0.00017	0.00134	CcSEcCtD
L-Carnitine—CROT—Metabolism—YAP1—ovarian cancer	0.000169	0.00313	CbGpPWpGaD
L-Carnitine—Dizziness—Paclitaxel—ovarian cancer	0.000169	0.00133	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000168	0.00309	CbGpPWpGaD
L-Carnitine—Anaemia—Epirubicin—ovarian cancer	0.000165	0.0013	CcSEcCtD
L-Carnitine—Vomiting—Paclitaxel—ovarian cancer	0.000162	0.00128	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—ovarian cancer	0.000162	0.00128	CcSEcCtD
L-Carnitine—Rash—Paclitaxel—ovarian cancer	0.000161	0.00127	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—PIK3CA—ovarian cancer	0.000161	0.00297	CbGpPWpGaD
L-Carnitine—Dermatitis—Paclitaxel—ovarian cancer	0.000161	0.00127	CcSEcCtD
L-Carnitine—Vertigo—Epirubicin—ovarian cancer	0.000161	0.00127	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN1B—ovarian cancer	0.00016	0.00296	CbGpPWpGaD
L-Carnitine—Back pain—Doxorubicin—ovarian cancer	0.00016	0.00126	CcSEcCtD
L-Carnitine—Headache—Paclitaxel—ovarian cancer	0.00016	0.00126	CcSEcCtD
L-Carnitine—Hypersensitivity—Docetaxel—ovarian cancer	0.000159	0.00126	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—ovarian cancer	0.000159	0.00125	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CYTB—ovarian cancer	0.000158	0.00292	CbGpPWpGaD
L-Carnitine—Palpitations—Epirubicin—ovarian cancer	0.000158	0.00124	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000156	0.00289	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000156	0.00289	CbGpPWpGaD
L-Carnitine—Cough—Epirubicin—ovarian cancer	0.000156	0.00123	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—TP53—ovarian cancer	0.000156	0.00287	CbGpPWpGaD
L-Carnitine—Asthenia—Docetaxel—ovarian cancer	0.000155	0.00122	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—ovarian cancer	0.000155	0.00122	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000155	0.00286	CbGpPWpGaD
L-Carnitine—Hypertension—Epirubicin—ovarian cancer	0.000154	0.00122	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000153	0.00283	CbGpPWpGaD
L-Carnitine—Pruritus—Docetaxel—ovarian cancer	0.000153	0.00121	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CCND1—ovarian cancer	0.000153	0.00282	CbGpPWpGaD
L-Carnitine—Anaemia—Doxorubicin—ovarian cancer	0.000153	0.0012	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—ovarian cancer	0.000152	0.0012	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—ovarian cancer	0.000152	0.0012	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—ovarian cancer	0.000152	0.00119	CcSEcCtD
L-Carnitine—Nausea—Paclitaxel—ovarian cancer	0.000152	0.00119	CcSEcCtD
L-Carnitine—Vertigo—Doxorubicin—ovarian cancer	0.000149	0.00117	CcSEcCtD
L-Carnitine—Diarrhoea—Docetaxel—ovarian cancer	0.000148	0.00117	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—MYC—ovarian cancer	0.000148	0.00272	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000147	0.00272	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000147	0.00272	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000146	0.0027	CbGpPWpGaD
L-Carnitine—Palpitations—Doxorubicin—ovarian cancer	0.000146	0.00115	CcSEcCtD
L-Carnitine—Infection—Epirubicin—ovarian cancer	0.000145	0.00114	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000144	0.00267	CbGpPWpGaD
L-Carnitine—Cough—Doxorubicin—ovarian cancer	0.000144	0.00114	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—YAP1—ovarian cancer	0.000144	0.00266	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—YAP1—ovarian cancer	0.000144	0.00266	CbGpPWpGaD
L-Carnitine—Convulsion—Doxorubicin—ovarian cancer	0.000143	0.00113	CcSEcCtD
L-Carnitine—Dizziness—Docetaxel—ovarian cancer	0.000143	0.00113	CcSEcCtD
L-Carnitine—Hypertension—Doxorubicin—ovarian cancer	0.000143	0.00112	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000143	0.00263	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000143	0.00263	CbGpPWpGaD
L-Carnitine—Tachycardia—Epirubicin—ovarian cancer	0.000142	0.00112	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000141	0.00261	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000141	0.0026	CbGpPWpGaD
L-Carnitine—Myalgia—Doxorubicin—ovarian cancer	0.000141	0.00111	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—ovarian cancer	0.000141	0.00111	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—ovarian cancer	0.00014	0.00111	CcSEcCtD
L-Carnitine—Anorexia—Epirubicin—ovarian cancer	0.000139	0.0011	CcSEcCtD
L-Carnitine—CPT2—Metabolism—PPP1CC—ovarian cancer	0.000138	0.00255	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—BRIP1—ovarian cancer	0.000138	0.00255	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—FASN—ovarian cancer	0.000138	0.00255	CbGpPWpGaD
L-Carnitine—Vomiting—Docetaxel—ovarian cancer	0.000138	0.00108	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000137	0.00254	CbGpPWpGaD
L-Carnitine—Rash—Docetaxel—ovarian cancer	0.000136	0.00107	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—ovarian cancer	0.000136	0.00107	CcSEcCtD
L-Carnitine—Dermatitis—Docetaxel—ovarian cancer	0.000136	0.00107	CcSEcCtD
L-Carnitine—CROT—Metabolism—SLC5A5—ovarian cancer	0.000136	0.00251	CbGpPWpGaD
L-Carnitine—Headache—Docetaxel—ovarian cancer	0.000136	0.00107	CcSEcCtD
L-Carnitine—Infection—Doxorubicin—ovarian cancer	0.000134	0.00106	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000133	0.00105	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000132	0.00244	CbGpPWpGaD
L-Carnitine—Insomnia—Epirubicin—ovarian cancer	0.000132	0.00104	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—ovarian cancer	0.000132	0.00104	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—NRAS—ovarian cancer	0.000132	0.00243	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—AKT1—ovarian cancer	0.000131	0.00242	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SLC2A1—ovarian cancer	0.000131	0.00242	CbGpPWpGaD
L-Carnitine—Paraesthesia—Epirubicin—ovarian cancer	0.000131	0.00103	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—ovarian cancer	0.00013	0.00102	CcSEcCtD
L-Carnitine—Anorexia—Doxorubicin—ovarian cancer	0.000129	0.00101	CcSEcCtD
L-Carnitine—Nausea—Docetaxel—ovarian cancer	0.000129	0.00101	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000128	0.00237	CbGpPWpGaD
L-Carnitine—Dyspepsia—Epirubicin—ovarian cancer	0.000128	0.00101	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—ovarian cancer	0.000127	0.000999	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000126	0.00233	CbGpPWpGaD
L-Carnitine—Hypotension—Doxorubicin—ovarian cancer	0.000126	0.000994	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000126	0.000992	CcSEcCtD
L-Carnitine—CROT—Metabolism—CYP1B1—ovarian cancer	0.000126	0.00232	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000125	0.00231	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000125	0.00231	CbGpPWpGaD
L-Carnitine—Pain—Epirubicin—ovarian cancer	0.000125	0.000983	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—ovarian cancer	0.000125	0.000983	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000123	0.000969	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—ovarian cancer	0.000123	0.00226	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—ovarian cancer	0.000122	0.00225	CbGpPWpGaD
L-Carnitine—Insomnia—Doxorubicin—ovarian cancer	0.000122	0.000962	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000122	0.00225	CbGpPWpGaD
L-Carnitine—Paraesthesia—Doxorubicin—ovarian cancer	0.000121	0.000955	CcSEcCtD
L-Carnitine—Dyspnoea—Doxorubicin—ovarian cancer	0.00012	0.000948	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000119	0.00094	CcSEcCtD
L-Carnitine—Dyspepsia—Doxorubicin—ovarian cancer	0.000119	0.000936	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000118	0.00217	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—FASN—ovarian cancer	0.000117	0.00217	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—FASN—ovarian cancer	0.000117	0.00217	CbGpPWpGaD
L-Carnitine—Decreased appetite—Doxorubicin—ovarian cancer	0.000117	0.000924	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000117	0.000918	CcSEcCtD
L-Carnitine—CRAT—Metabolism—SLC5A5—ovarian cancer	0.000116	0.00213	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SLC5A5—ovarian cancer	0.000116	0.00213	CbGpPWpGaD
L-Carnitine—Constipation—Doxorubicin—ovarian cancer	0.000115	0.000909	CcSEcCtD
L-Carnitine—Pain—Doxorubicin—ovarian cancer	0.000115	0.000909	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—ovarian cancer	0.000115	0.000908	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—ovarian cancer	0.000115	0.000908	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—KRAS—ovarian cancer	0.000113	0.00209	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NME2—ovarian cancer	0.000113	0.00208	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—IL6—ovarian cancer	0.000112	0.00206	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SLC2A1—ovarian cancer	0.000112	0.00206	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SLC2A1—ovarian cancer	0.000112	0.00206	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PPP2R1A—ovarian cancer	0.000112	0.00206	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000112	0.00206	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000111	0.00205	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000111	0.00204	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00011	0.000869	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.00011	0.00203	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYTB—ovarian cancer	0.00011	0.00203	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000109	0.00202	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000109	0.00202	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Epirubicin—ovarian cancer	0.000108	0.000847	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000107	0.00198	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000107	0.00198	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1B1—ovarian cancer	0.000107	0.00197	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP1B1—ovarian cancer	0.000107	0.00197	CbGpPWpGaD
L-Carnitine—Body temperature increased—Doxorubicin—ovarian cancer	0.000107	0.000841	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—ovarian cancer	0.000107	0.000841	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000106	0.00196	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000106	0.00196	CbGpPWpGaD
L-Carnitine—Asthenia—Epirubicin—ovarian cancer	0.000105	0.000824	CcSEcCtD
L-Carnitine—CROT—Metabolism—ABCB1—ovarian cancer	0.000104	0.00191	CbGpPWpGaD
L-Carnitine—Pruritus—Epirubicin—ovarian cancer	0.000103	0.000813	CcSEcCtD
L-Carnitine—CROT—Metabolism—TYMS—ovarian cancer	0.000102	0.00188	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000101	0.00186	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.0001	0.00185	CbGpPWpGaD
L-Carnitine—Diarrhoea—Epirubicin—ovarian cancer	9.98e-05	0.000786	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	9.95e-05	0.00184	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Doxorubicin—ovarian cancer	9.95e-05	0.000783	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—PTEN—ovarian cancer	9.69e-05	0.00179	CbGpPWpGaD
L-Carnitine—Asthenia—Doxorubicin—ovarian cancer	9.69e-05	0.000763	CcSEcCtD
L-Carnitine—Dizziness—Epirubicin—ovarian cancer	9.65e-05	0.00076	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—ovarian cancer	9.63e-05	0.00178	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	9.61e-05	0.00177	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPP1CC—ovarian cancer	9.59e-05	0.00177	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—BRIP1—ovarian cancer	9.59e-05	0.00177	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.59e-05	0.00177	CbGpPWpGaD
L-Carnitine—Pruritus—Doxorubicin—ovarian cancer	9.55e-05	0.000752	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—PPP2R1A—ovarian cancer	9.48e-05	0.00175	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPP2R1A—ovarian cancer	9.48e-05	0.00175	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.44e-05	0.00174	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.44e-05	0.00174	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—YAP1—ovarian cancer	9.28e-05	0.00171	CbGpPWpGaD
L-Carnitine—Vomiting—Epirubicin—ovarian cancer	9.28e-05	0.000731	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—ovarian cancer	9.24e-05	0.000727	CcSEcCtD
L-Carnitine—Rash—Epirubicin—ovarian cancer	9.2e-05	0.000725	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—ovarian cancer	9.19e-05	0.000724	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.19e-05	0.0017	CbGpPWpGaD
L-Carnitine—Headache—Epirubicin—ovarian cancer	9.14e-05	0.00072	CcSEcCtD
L-Carnitine—Dizziness—Doxorubicin—ovarian cancer	8.93e-05	0.000703	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—IL6—ovarian cancer	8.88e-05	0.00164	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ABCB1—ovarian cancer	8.81e-05	0.00163	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ABCB1—ovarian cancer	8.81e-05	0.00163	CbGpPWpGaD
L-Carnitine—Nausea—Epirubicin—ovarian cancer	8.67e-05	0.000683	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—TYMS—ovarian cancer	8.65e-05	0.0016	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—TYMS—ovarian cancer	8.65e-05	0.0016	CbGpPWpGaD
L-Carnitine—Vomiting—Doxorubicin—ovarian cancer	8.58e-05	0.000676	CcSEcCtD
L-Carnitine—Rash—Doxorubicin—ovarian cancer	8.51e-05	0.00067	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—ovarian cancer	8.51e-05	0.00067	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—ovarian cancer	8.46e-05	0.000666	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	8.38e-05	0.00155	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—CAV1—ovarian cancer	8.2e-05	0.00151	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.08e-05	0.00149	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—ovarian cancer	8.02e-05	0.000632	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.83e-05	0.00145	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—IL6—ovarian cancer	7.77e-05	0.00143	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—AQP3—ovarian cancer	7.59e-05	0.0014	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.58e-05	0.0014	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—FASN—ovarian cancer	7.57e-05	0.0014	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	7.56e-05	0.00139	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.51e-05	0.00139	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CG—ovarian cancer	7.47e-05	0.00138	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC5A5—ovarian cancer	7.44e-05	0.00137	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.44e-05	0.00137	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—IL6—ovarian cancer	7.42e-05	0.00137	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	7.3e-05	0.00135	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	7.28e-05	0.00134	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYTB—ovarian cancer	7.27e-05	0.00134	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC2A1—ovarian cancer	7.19e-05	0.00133	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.19e-05	0.00133	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.04e-05	0.0013	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.99e-05	0.00129	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CAV1—ovarian cancer	6.97e-05	0.00129	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CAV1—ovarian cancer	6.97e-05	0.00129	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1B1—ovarian cancer	6.89e-05	0.00127	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.66e-05	0.00123	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.66e-05	0.00123	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—ovarian cancer	6.61e-05	0.00122	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CD—ovarian cancer	6.56e-05	0.00121	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—YAP1—ovarian cancer	6.43e-05	0.00119	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.37e-05	0.00117	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPP1CC—ovarian cancer	6.35e-05	0.00117	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BRIP1—ovarian cancer	6.35e-05	0.00117	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CG—ovarian cancer	6.35e-05	0.00117	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CG—ovarian cancer	6.35e-05	0.00117	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPP2R1A—ovarian cancer	6.11e-05	0.00113	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.08e-05	0.00112	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—IL6—ovarian cancer	6.05e-05	0.00112	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NME2—ovarian cancer	5.94e-05	0.0011	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.76e-05	0.00106	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CB—ovarian cancer	5.72e-05	0.00106	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ABCB1—ovarian cancer	5.68e-05	0.00105	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.67e-05	0.00105	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.6e-05	0.00103	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.59e-05	0.00103	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CD—ovarian cancer	5.58e-05	0.00103	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CD—ovarian cancer	5.58e-05	0.00103	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—TYMS—ovarian cancer	5.57e-05	0.00103	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.4e-05	0.000997	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—FASN—ovarian cancer	5.24e-05	0.000968	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC5A5—ovarian cancer	5.16e-05	0.000952	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.06e-05	0.000933	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.04e-05	0.000929	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC2A1—ovarian cancer	4.98e-05	0.000919	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—ovarian cancer	4.94e-05	0.000912	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.88e-05	0.000901	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.88e-05	0.0009	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CB—ovarian cancer	4.86e-05	0.000898	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CB—ovarian cancer	4.86e-05	0.000898	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1B1—ovarian cancer	4.78e-05	0.000882	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CAV1—ovarian cancer	4.49e-05	0.000829	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.29e-05	0.000792	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.26e-05	0.000787	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—YAP1—ovarian cancer	4.26e-05	0.000786	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPP2R1A—ovarian cancer	4.24e-05	0.000782	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.22e-05	0.000778	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—ovarian cancer	4.2e-05	0.000776	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—ovarian cancer	4.2e-05	0.000776	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.11e-05	0.000758	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—ovarian cancer	4.09e-05	0.000755	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ABCB1—ovarian cancer	3.93e-05	0.000726	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TYMS—ovarian cancer	3.86e-05	0.000713	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.86e-05	0.000712	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.84e-05	0.000709	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYTB—ovarian cancer	3.83e-05	0.000706	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.74e-05	0.00069	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.71e-05	0.000684	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CD—ovarian cancer	3.6e-05	0.000664	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—ovarian cancer	3.49e-05	0.000644	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—FASN—ovarian cancer	3.47e-05	0.000641	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC5A5—ovarian cancer	3.42e-05	0.000631	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BRIP1—ovarian cancer	3.34e-05	0.000617	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	3.34e-05	0.000617	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A1—ovarian cancer	3.3e-05	0.000609	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1B1—ovarian cancer	3.16e-05	0.000584	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CB—ovarian cancer	3.13e-05	0.000578	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CAV1—ovarian cancer	3.11e-05	0.000574	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.97e-05	0.000549	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—ovarian cancer	2.97e-05	0.000547	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—ovarian cancer	2.97e-05	0.000547	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.93e-05	0.00054	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—ovarian cancer	2.85e-05	0.000526	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—ovarian cancer	2.84e-05	0.000523	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPP2R1A—ovarian cancer	2.81e-05	0.000518	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—ovarian cancer	2.71e-05	0.0005	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ABCB1—ovarian cancer	2.61e-05	0.000481	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TYMS—ovarian cancer	2.56e-05	0.000472	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CD—ovarian cancer	2.49e-05	0.00046	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.44e-05	0.00045	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—ovarian cancer	2.42e-05	0.000447	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—ovarian cancer	2.42e-05	0.000447	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—YAP1—ovarian cancer	2.24e-05	0.000414	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.22e-05	0.00041	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CB—ovarian cancer	2.17e-05	0.000401	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CAV1—ovarian cancer	2.06e-05	0.000381	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.95e-05	0.00036	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—ovarian cancer	1.91e-05	0.000353	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—ovarian cancer	1.88e-05	0.000347	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—ovarian cancer	1.88e-05	0.000346	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—FASN—ovarian cancer	1.83e-05	0.000337	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.8e-05	0.000332	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.74e-05	0.000321	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.7e-05	0.000314	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.67e-05	0.000307	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CD—ovarian cancer	1.65e-05	0.000305	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—ovarian cancer	1.56e-05	0.000288	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.48e-05	0.000273	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.47e-05	0.000271	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CB—ovarian cancer	1.44e-05	0.000266	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.37e-05	0.000253	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.35e-05	0.000249	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—ovarian cancer	1.32e-05	0.000244	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—ovarian cancer	1.24e-05	0.00023	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.09e-05	0.0002	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—ovarian cancer	1.08e-05	0.0002	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.04e-05	0.000191	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	9.89e-06	0.000182	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—ovarian cancer	8.77e-06	0.000162	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	8.69e-06	0.00016	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	7.58e-06	0.00014	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—ovarian cancer	7.17e-06	0.000132	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—ovarian cancer	6.55e-06	0.000121	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	4.62e-06	8.52e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—ovarian cancer	3.77e-06	6.96e-05	CbGpPWpGaD
